{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Study Finds Link Between Lorazepam & Worse Outcomes in Pancreatic Cancer

Activity Steps

1 Activity
2 Take Test 3Certificate

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain initial study findings demonstrating a relationship between benzodiazepines and survival outcomes in cancer patients and summarize their implications for clinical practice and research.
  2. Identify the associated issues related to pancreatic cancer tumor microenvironment and cancer-associated fibroblast signaling.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of a study exploring the connection between benzodiazepines and survival outcomes in cancer patients as well as the pancreatic cancer tumor microenvironment and cancer-associated fibroblast signaling by achieving a minimum score of 70% on the posttest.

Disclosures

All authors, faculty, staff, and planners have no relevant financial relationships with any ineligible organizations regarding this educational activity.

Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • FL - BON 1.0 CH
  • GA - BON 1.0 CH
  • NM - BON 1.0 CH
  • SC - BON 1.0 CH
  • WV - BOERN 1.0 CH

Lippincott Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Planner
Test Code: OT1023
Published: October 2023
Expires: 9/5/2025
Sources: Oncology Times
Required Passing Score: 4/5 (80%)
Authors: Catlin Nalley
Categories: Advanced Practice Nursing , Cancer , Drug Therapy , Oncology
Specialties: Advanced Practice Nursing, Oncology
Topics: Benzodiazepines , Cancer , Chemotherapy